⌘K

Candel Therapeutics, Inc. (CADL)

$7.28 3.85% $0.27 Healthcare

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. It also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent glioblastoma. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. The company was incorporated in 2003 and is based in Needham, Massachusetts.

Market cap

$233.58M

CEO

Dr. Paul-Peter Tak FMEDSCI, M.D., Ph.D.

Full time employees

65.00

Headquarters

Needham, MA

IPO Date

Jul 23, 2021

Price-to-earnings (PE) Ratio

-4.28

Earnings-per-share (EPS)

$-1.70

Cash ratio (TTM)

1.53

Current ratio (TTM)

1.62

Net profit margin (TTM)

-2,814.64%

PE ratio (TTM)

-4.19

PEG ratio (TTM)

0.06

Price-to-book ratio (TTM)

-21.00

Price-to-sales ratio (TTM)

126.64

Quick ratio (TTM)

1.62

Return on assets (TTM)

-188.74%

Return on equity (TTM)

-629.29%

Similar stocks (13)

PepGen Inc.

PEPG

$9.12 -3.80% $-0.36

Downtrend

Rezolute, Inc.

RZLT

$5.15 -1.90% $-0.10

Uptrend

Acrivon Therapeutics, Inc. Common Stock

ACRV

$8.23 -7.63% $-0.68

Uptrend

PMV Pharmaceuticals, Inc.

PMVP

$1.50 -0.66% $-0.01

Downtrend

Aerovate Therapeutics, Inc.

AVTE

$1.91 0.53% $0.01

Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$2.09 0.00% $0.00

Downtrend

Tempest Therapeutics, Inc.

TPST

$1.36 -6.21% $-0.09

Downtrend

Acurx Pharmaceuticals, Inc.

ACXP

$2.02 -0.98% $-0.02

Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.05 0.96% $0.01

Downtrend

Indaptus Therapeutics, Inc.

INDP

$1.56 0.00% $0.00

Downtrend

Monopar Therapeutics Inc.

MNPR

$4.19 8.55% $0.33

Neutral

Forte Biosciences, Inc.

FBRX

$7.33 4.12% $0.29

Downtrend

Comera Life Sciences Holdings, Inc.

CMRA

$0.02 0.00% $0.00

Downtrend

ETF Exposure (16)

iShares Micro-Cap ETF

IWC

0.0331%

$122.64 -0.28% $-0.34

Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0.01%

$202.06 0.06% $0.12

Neutral

iShares Russell 2000 Growth ETF

IWO

0.00987%

$277.57 0.12% $0.34

Uptrend

iShares Russell 2000 ETF

IWM

0.0049%

$217.67 0.39% $0.84

Uptrend

ProShares Ultra Russell2000

UWM

0.0018517435129338051%

$41.65 0.77% $0.32

Neutral

ProShares UltraPro Russell2000

URTY

9.138936324800532e-4%

$49.88 1.11% $0.55

Neutral

ProShares Hedge Replication ETF

HDG

7.70267211705936e-4%

$49.80 0.13% $0.06

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$134.52 1.86% $2.45

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.10 0.71% $0.68

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.07 0.71% $0.68

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.94 0.72% $0.96

Uptrend

Vanguard Russell 3000 Index Fund

VTHR

$249.12 0.18% $0.44

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$277.72 0.18% $0.50

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.92 0.72% $0.96

Uptrend

Vanguard Russell 2000 Index Fund

VTWO

$88.01 0.39% $0.34

Neutral

Vanguard Extended Market Index Fund

VXF

$178.36 0.55% $0.97

Uptrend

Similar stocks (13)

PepGen Inc.

PEPG

$9.12 -3.80% $-0.36

Downtrend

Rezolute, Inc.

RZLT

$5.15 -1.90% $-0.10

Uptrend

Acrivon Therapeutics, Inc. Common Stock

ACRV

$8.23 -7.63% $-0.68

Uptrend

PMV Pharmaceuticals, Inc.

PMVP

$1.50 -0.66% $-0.01

Downtrend

Aerovate Therapeutics, Inc.

AVTE

$1.91 0.53% $0.01

Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$2.09 0.00% $0.00

Downtrend

Tempest Therapeutics, Inc.

TPST

$1.36 -6.21% $-0.09

Downtrend

Acurx Pharmaceuticals, Inc.

ACXP

$2.02 -0.98% $-0.02

Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.05 0.96% $0.01

Downtrend

Indaptus Therapeutics, Inc.

INDP

$1.56 0.00% $0.00

Downtrend

Monopar Therapeutics Inc.

MNPR

$4.19 8.55% $0.33

Neutral

Forte Biosciences, Inc.

FBRX

$7.33 4.12% $0.29

Downtrend

Comera Life Sciences Holdings, Inc.

CMRA

$0.02 0.00% $0.00

Downtrend

ETF Exposure (16)

iShares Micro-Cap ETF

IWC

0.0331%

$122.64 -0.28% $-0.34

Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0.01%

$202.06 0.06% $0.12

Neutral

iShares Russell 2000 Growth ETF

IWO

0.00987%

$277.57 0.12% $0.34

Uptrend

iShares Russell 2000 ETF

IWM

0.0049%

$217.67 0.39% $0.84

Uptrend

ProShares Ultra Russell2000

UWM

0.0018517435129338051%

$41.65 0.77% $0.32

Neutral

ProShares UltraPro Russell2000

URTY

9.138936324800532e-4%

$49.88 1.11% $0.55

Neutral

ProShares Hedge Replication ETF

HDG

7.70267211705936e-4%

$49.80 0.13% $0.06

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$134.52 1.86% $2.45

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.10 0.71% $0.68

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.07 0.71% $0.68

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.94 0.72% $0.96

Uptrend

Vanguard Russell 3000 Index Fund

VTHR

$249.12 0.18% $0.44

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$277.72 0.18% $0.50

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.92 0.72% $0.96

Uptrend

Vanguard Russell 2000 Index Fund

VTWO

$88.01 0.39% $0.34

Neutral

Vanguard Extended Market Index Fund

VXF

$178.36 0.55% $0.97

Uptrend